RT Answers News
— Kojo Nnamdi Show -- March 9, 2010
Medical radiation has saved countless lives and helped many patients avoid the risks of exploratory surgery. Yet a recent New York Times investigation found that some radiation patients have been seriously harmed by human and computer error. We'll discuss the increasingly sophisticated technology, and a new push for more training and oversight of hospitals that provide these treatments. Anthony Zietman, M.D., speaks with Kojo and Walt Bogdanich of The New York Times on this topic.
— Imaging and Technology News -- January 5, 2010
Sexual function in prostate cancer patients receiving external beam radiation therapy (EBRT) decreases within the first two years after treatment, but then stabilizes and does not continuously decline as was previously thought, according to a study in the January 1 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of the American Society for Radiation Oncology (ASTRO).
— Aunt Minnie -- December 22, 2009
Accelerated partial-breast irradiation (APBI) has carved out a niche as a valuable tool in treating low-risk patients with early-stage breast cancer. But could the technique also have a role in patients at increased risk? Maybe, according to a set of recent clinical studies.
— Renal and Urology News -- December 10, 2009
Improved radiotherapy techniques have made it possible for men to achieve reductions in PSA to below detectable levels following radiation treatment for prostate cancer, according to new findings presented here at the American Society for Radiation Oncology's 51st Annual Meeting.
— Better Health Research -- December 2, 2009
The PSA levels of prostate cancer patients two years after treatment may be an indication of long-term survival.
— Physorg.com -- December 2, 2009
Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).
— Cancer Network -- November 23, 2009
Precise and noninvasive, stereotactic radiosurgery is proving a godsend to some noncancer patients. Its use for applications outside oncology, such as the treatment of movement disorders, arteriovenous malformations, and neuralgia, have been around almost since the commercial introduction of this technology.
— DOTmed -- November 20, 2009
DOTmed discusses the American Society for Radiation Oncology (ASTRO) program for public awareness with ASTRO's assistant director of communications, Beth Bukata.
— Science Daily -- November 20, 2009
Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy, according to a largest of its kind study in the November 15 issue of the International Journal of Radiation Oncology*Biology*Physics.
— Hospimedia -- November 16, 2009
A highly-targeted form of radiation therapy called proton beam therapy can be used to treat prostate cancer, and may even prevent the cancer from coming back, two new studies suggest.
— Gainesville Sun -- November 13, 2009
A highly-targeted form of radiation therapy called proton beam therapy can be used to treat prostate cancer, and may even prevent the cancer from coming back, two new studies suggest.
— Cancer Consultants -- November 11, 2009
Researchers from the UK have reported that patients with locally advanced bladder cancer treated with concomitant carbogen, nicotinamide, and radical accelerated radiotherapy have a 13 percent improved three-year survival compared with patients treated with radiotherapy alone.
— CNN.com -- November 5, 2009
A study presented at the ASTRO Annual Meeting gives us insight on what cancer patients want from their doctors.
